BARCA, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 1.747
AS - Asia 992
EU - Europa 980
SA - Sud America 375
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.126
Nazione #
US - Stati Uniti d'America 1.719
SG - Singapore 379
CN - Cina 342
BR - Brasile 334
IE - Irlanda 320
SE - Svezia 274
HK - Hong Kong 120
IT - Italia 72
PL - Polonia 61
DE - Germania 58
FI - Finlandia 58
VN - Vietnam 52
RU - Federazione Russa 42
GB - Regno Unito 33
IN - India 27
BE - Belgio 17
AR - Argentina 13
ZA - Sudafrica 13
MX - Messico 12
JP - Giappone 11
TR - Turchia 10
CA - Canada 9
FR - Francia 9
ID - Indonesia 9
NL - Olanda 9
UA - Ucraina 9
EC - Ecuador 8
IQ - Iraq 8
PK - Pakistan 7
BD - Bangladesh 6
MA - Marocco 6
IR - Iran 5
VE - Venezuela 5
CI - Costa d'Avorio 4
ES - Italia 4
PY - Paraguay 4
AT - Austria 3
UY - Uruguay 3
UZ - Uzbekistan 3
BO - Bolivia 2
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IL - Israele 2
KZ - Kazakistan 2
MD - Moldavia 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
EU - Europa 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
Totale 4.126
Città #
Dublin 319
Dallas 292
Chandler 210
Singapore 180
Ashburn 165
Nyköping 150
Beijing 131
Hong Kong 120
Dearborn 66
Ann Arbor 61
Warsaw 61
Jacksonville 59
Los Angeles 54
Princeton 54
Cambridge 51
Medford 50
The Dalles 43
Des Moines 40
New York 38
Munich 24
Jinan 23
San Mateo 23
São Paulo 23
Messina 22
Wilmington 21
Shenyang 19
Boardman 18
Buffalo 18
Moscow 18
Lancaster 16
Brussels 15
Ho Chi Minh City 15
Houston 15
Redondo Beach 15
Ningbo 14
Tianjin 13
Nanjing 12
Hangzhou 11
Hanoi 11
Tokyo 11
Belo Horizonte 10
Hebei 10
Hyderabad 10
Rio de Janeiro 10
Santa Clara 10
Bremen 9
Rome 9
Brasília 8
Taizhou 8
Turku 8
Campinas 7
Changsha 7
Haikou 7
Salvador 7
Zhengzhou 7
Cagliari 6
Chennai 6
Helsinki 6
Jakarta 6
Johannesburg 6
Alvorada 5
Brooklyn 5
Denver 5
Düsseldorf 5
Manaus 5
Norwalk 5
Orem 5
Pune 5
Abidjan 4
Ankara 4
Asunción 4
Atlanta 4
Boston 4
Catania 4
Curitiba 4
Dong Ket 4
Fairfield 4
Haiphong 4
Mexico City 4
Milan 4
Montreal 4
Phoenix 4
Santo André 4
Toronto 4
Washington 4
Ardabil 3
Cabo Frio 3
Campo Grande 3
Can Tho 3
Falls Church 3
Fortaleza 3
Frankfurt am Main 3
Fuzhou 3
Guangzhou 3
Guayaquil 3
Hefei 3
Itabira 3
Jiaxing 3
João Pessoa 3
Juiz de Fora 3
Totale 2.811
Nome #
A life threatening case of β-enolase deficiency 141
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 133
Auditory system involvement study in 20 patients with late-onset Pompe disease 133
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 131
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias 123
A MRI evaluation of respiratory function in patients with the late onset form of Pompe disease 119
ANT1 is reduced in sporadic inclusion body myositis. 118
Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy 115
A study of auditory system in 20 patients with late onset Pompe disease 112
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study 111
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 111
Auditory system involvement study in 20 patients with lateonset pompe disease 108
The Role of Mitochondria in Cerebellar Ataxias 108
Clinical and electrophysiological characterization in a cohort of italian patients with different forms of hereditary spastic paraplegia 105
Are there ERT defined guidelines for Pompe disease? 94
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 93
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 93
Clinical, morphological and genetic features of a large cohort of late onset GSDII patients: typical and atypical presentation 88
Ruolo patogenetico dei microRNAs nelle calpainopatie 87
Metabolic Myoglobinuria 87
CEREBELLAR ATAXIA AND SEVERE MUSCLE CoQ10 DEFICIENCY IN A PATIENT WITH A NOVEL MUTATION IN ADCK3 87
ANO10 mutations cause ataxia and coenzyme Q₁₀ deficiency 86
Chapter 34 - Primary Cerebellar CoQ10 Deficiency 85
An unusual clinical presentation of Pompe disease charactherized by a severe distal myopathy 82
The Italian Mitochondrial Registry: design and preliminary results 81
Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial Patients 79
Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway 75
CoQ10 Deficiency Is Not a Common Finding in GLUT1 Deficiency Syndrome 74
Late-onset Pompe disease (LOPD): Correlations between respiratory muscles CT and MRI features and pulmonary function 73
Muscle imaging findings in GNE myopathy. 72
Coinvolgimento muscolare in un caso di sindrome di Sweet (dermatosi neutrofila febbrile) 70
Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum 70
Wound botulism in drug users: a still underestimated diagnosis 69
Deoxynucleoside stress exacerbates the phenotype of a mouse model of mitochondrial neurogastrointestinal encephalopathy 68
Un caso di rabdomiolisi massiva da deficit di β-enolasi 67
Differential expression of microRNAs in primary and secondary calpainopathies 67
The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene 66
Functional cellular analyses reveal energy metabolism defect and mitochondrial DNA depletion in a case of mitochondrial aconitase deficiency 64
Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway 56
New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy 56
Quantitative muscle MRI and functional measures in a cohort of late onset GSD II patients 55
Differential expression of microRNAs in primary and secondary calpainopathies 54
Muscle gene expression profile in adult onset patients with Pompe disease 52
Role of the autophagic process in adult-onset patients with Pompe disease 52
Therapeutic approaches in the late onset form of GSD II 51
Role of the autophagic process in adult-onset patients with Pompe disease 51
Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency 51
Update on diagnostics of metabolic myopathies 50
Cytochrome c Oxidase Activity Is a Metabolic Checkpoint that Regulates Cell Fate Decisions During T Cell Activation and Differentiation 49
Inhibition of NAPDH Oxidase 2 (NOX2) Prevents Oxidative Stress and Mitochondrial Abnormalities Caused by Saturated Fat in Cardiomyocytes 48
Ruolo del processo autofagico nella forma ad insorgenza adulta di malattia di Pompe 47
Totale 4.217
Categoria #
all - tutte 16.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021127 0 0 0 0 0 7 15 12 9 46 29 9
2021/2022395 3 40 4 25 19 4 35 18 8 67 56 116
2022/2023828 61 86 28 57 60 92 3 48 360 3 25 5
2023/2024206 22 26 21 19 17 37 1 14 1 20 3 25
2024/2025871 13 5 12 41 31 68 2 165 258 58 69 149
2025/20261.118 135 249 246 243 235 10 0 0 0 0 0 0
Totale 4.217